Reduced Membrane Lipids in the Cortex of Alzheimer’s Disease Transgenic Mice

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurochemical Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11064-008-9673-1PMID 18373196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Docosahexaenoic acid stimulates non‐amyloidogenic APP processing resulting in reduced Aβ levels in cellular models of Alzheimer's disease

  2007cited by this paper
• The β‐amyloid protein of Alzheimer’s disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor

  2007cited by this paper
• The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor.

  2007cited by this paper
• Low serum docosahexaenoic acid is a significant risk factor for alzheimer’s dementia

  2007cited by this paper
• An improved method for rapid analysis of the fatty acids of glycerolipids

  2006cited by this paper
• Phospholipases A2 Mediate Amyloid-β Peptide-Induced Mitochondrial Dysfunction

  2006cited by this paper
• Phospholipase A₂-Generated Lipid Mediators in the Brain: The Good, the Bad, and the Ugly

  2006cited by this paper
• Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly.

  2006cited by this paper
• Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin

  2005cited by this paper
• A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model

  2005cited by this paper
• Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.

  2004cited by this paper
• Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.

  2004cited by this paper
• Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease.

  2003cited by this paper
• Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Lipid Metabolism, Epidemiology, and the Mechanisms of Alzheimer's Disease

  2002cited by this paper
• Cholesterol Is an Important Factor Affecting the Membrane Insertion of β-Amyloid Peptide (Aβ1–40), Which May Potentially Inhibit the Fibril Formation*

  2002cited by this paper
• Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation.

  2002cited by this paper
• Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.

  2001influential reference
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• The Evolution of Aβ Peptide Burden in the APP23 Transgenic Mice: Implications for Aβ Deposition in Alzheimer Disease

  2001cited by this paper
• Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains*

  2001cited by this paper
• Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease

  2000cited by this paper
• Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients.

  2000influential reference
• Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.

  2000cited by this paper
• Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain.

  2000influential reference
• Diet and Oxidative Stress: A Novel Synthesis of Epidemiological Data on Alzheimer's Disease

  1999cited by this paper
• Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease

  1999cited by this paper
• Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

  1998cited by this paper
• n-3 versus n-6 polyunsaturated fatty acids in critical illness.

  1998cited by this paper
• Dietary Links to Alzheimer's Disease

  1997cited by this paper
• Dietary fat intake and the risk of incident dementia in the Rotterdam study

  1997cited by this paper
• Alzheimer's Disease Amyloid β Peptide 25-35 Is Localized in the Membrane Hydrocarbon Core: X-Ray Diffraction Analysis

  1996cited by this paper
• Amyloid β-Protein and the Genetics of Alzheimer's Disease*

  1996cited by this paper
• Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• An improved method for rapid analysis of the fatty acids of glycerolipids

  1996cited by this paper
• Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis.

  1996cited by this paper
• Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging.

  1995influential reference
• Dietary supplementation with very long‐chain n‐3 fatty acids in man decreases expression of the interleukin‐2 receptor (CD25) on mitogen‐stimulated lymphocytes from patients with inflammatory skin diseases

  1994cited by this paper
• Evidence for a membrane defect in Alzheimer disease brain.

  1992cited by this paper
• Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease

  1991cited by this paper
• Membrane Lipids in the Aging Human Brain

  1991cited by this paper
• Advances in Alzheimer's disease

  1991cited by this paper
• Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.

  1990cited by this paper
• 31P Nuclear Magnetic Resonance Study of the Brain in Alzheimer's Disease

  1988cited by this paper

• Quantitative analysis of targeted lipidomics in the hippocampus of APP/PS1 mice employing the UHPLC-MS/MS method

  2025cites this paper
• Phosphatidylserine: A comprehensive overview of synthesis, metabolism, and nutrition.

  2024cites this paper
• Phosphatidylserine, inflammation, and central nervous system diseases

  2022cites this paper
• Distinct brain lipid signatures in response to low-level PM2.5 exposure in a 3xTg-Alzheimer's disease mouse inhalation model.

  2022cites this paper
• Targeted Lipidomics To Measure Phospholipids and Sphingomyelins in Plasma: A Pilot Study To Understand the Impact of Race/Ethnicity in Alzheimer's Disease.

  2022cites this paper
• The prevalence and associated factors of motoric cognitive risk syndrome in multiple ethnic middle‐aged to older adults in west China: a cross‐sectional study

  2022cites this paper
• Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer’s Disease

  2021cites this paper
• Micro-Raman spectroscopy of lipid halo and dense-core amyloid plaques: aging process characterization in the Alzheimer's disease APPswePS1ΔE9 mouse model.

  2021cites this paper
• Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice

  2020cites this paper
• A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer’s Disease Biomarker

  2019cites this paper
• Lipid raft ER signalosome malfunctions in menopause and Alzheimer's disease.

  2017cites this paper
• Early Effect of Amyloid β-Peptide on Hippocampal and Serum Metabolism in Rats Studied by an Integrated Method of NMR-Based Metabolomics and ANOVA-Simultaneous Component Analysis

  2017cites this paper
• Alzheimer ' s disease ( AD )-like pathology has discontinuous effects on the brain and blood metabolome

  2016influential citation
• The Effects of Glycerophospholipids and Fatty Acids on APP Processing: Implications for Alzheimer’s Disease

  2016cites this paper
• Alzheimer's disease-like pathology has transient effects on the brain and blood metabolome.

  2016influential citation
• Metabolomics reveals significant impairments in the immune system of the APP/PS1 transgenic mice of Alzheimer's disease

  2015cites this paper
• Neuroprotective effects of estrogens: the role of cholesterol

  2015cites this paper
• Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.

  2015cites this paper
• Elsevier Editorial System(tm) for Journal of Pharmaceutical and Biomedical Analysis Manuscript Draft Manuscript Number: JPBA-D-14-01586R1 Title: APPLICATION OF METABOLOMICS BASED ON DIRECT MASS SPECTROMETRY ANALYSIS FOR THE ELUCIDATION OF ALTERED METABOLIC PATHWAYS IN SERUM FROM THE APP/PS1 TRANSGEN

  2015cites this paper
• Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry.

  2015cites this paper
• Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer’s Disease

  2015cites this paper
• Cellular Membrane Fluidity in Amyloid Precursor Protein Processing

  2014cites this paper
• Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease

  2014cites this paper
• Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.

  2014cites this paper
• Lipidomics of Alzheimer's disease.

  2014cites this paper
• Combined Reviewers ' comments : Compound Identification : 1

  2014cites this paper
• OXPHOS, Pyrimidine Nucleotides, and Alzheimer's Disease: A Pharmacogenomics Approach

  2014cites this paper
• Lipid raft disarrangement as a result of neuropathological progresses: a novel strategy for early diagnosis?

  2013cites this paper
• Discovery of new biomarkers of mild cognitive impairment and Alzheimer's disease risk in buccal cells using laser scanning cytometry

  2013cites this paper
• Hormonal modulation of cholesterol: experimental evidence and possible translational impact

  2012cites this paper
• Relationship Between the Neuroprotective Effects of Insulin‐Like Growth Factor‐1 and 17β‐Oestradiol in Human Neuroblasts

  2012cites this paper
• Evidence for Premature Lipid Raft Aging in APP/PS1 Double-Transgenic Mice, a Model of Familial Alzheimer Disease

  2012cites this paper
• Effects of membrane lipids on the activity and processivity of purified γ-secretase.

  2012cites this paper
• Membrane cholesterol as a mediator of the neuroprotective effects of estrogens.

  2011cites this paper
• Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.

  2011cites this paper
• Impacts of Membrane Biophysics in Alzheimer's Disease: From Amyloid Precursor Protein Processing to Aβ Peptide-Induced Membrane Changes

  2011cites this paper
• Systems Biology and the Discovery of Diagnostic Biomarkers

  2010cites this paper
• Deficiency of ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) leads to vulnerability to lipid peroxidation.

  2010cites this paper
• Targeting mitochondrial dysfunction in neurodegenerative disease: Part II

  2010cites this paper
• Targeting mitochondrial dysfunction in neurodegenerative disease: Part I

  2010cites this paper
• Alterations in Brain Cholesterol Metabolism in the APPSLxPS1mut mouse, a Model for Alzheimer's Disease

  2010cites this paper
• Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.

  2010cites this paper
• Brain sterol metabolism : modulating Alzheimer’s disease

  2010cites this paper
• Membrane Biophysics and Mechanics in Alzheimer's Disease

  2010cites this paper
• Insulin-resistant brain state (IRBS) changes membrane composition of fatty acids in temporal and entorhinal brain cortices of rats: relevance to sporadic Alzheimer’s disease?

  2010cites this paper
• High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.

  2010cites this paper
• Amyloid-β, Tau Protein, and Oxidative Changes as a Physiological Compensatory Mechanism to Maintain CNS Plasticity under Alzheimer's Disease and Other Neurodegenerative Conditions

  2009cites this paper
• New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm.

  2009cites this paper
• Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid β Protein

  2009cites this paper
• Analysis of Lipid Metabolism in Brain of p 25 Transgenic Mouse-A Model of Alzheimer ’ s Disease

  2008cites this paper
• Neuroprotective effects of the Alzheimer's disease-related gene seladin-1.

  2008cites this paper